KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Revenue (2016 - 2025)

Quest Diagnostics' Revenue history spans 17 years, with the latest figure at $2.8 billion for Q4 2025.

  • For Q4 2025, Revenue rose 7.06% year-over-year to $2.8 billion; the TTM value through Dec 2025 reached $11.0 billion, up 11.78%, while the annual FY2025 figure was $11.0 billion, 11.78% up from the prior year.
  • Revenue for Q4 2025 was $2.8 billion at Quest Diagnostics, roughly flat from $2.8 billion in the prior quarter.
  • Across five years, Revenue topped out at $2.8 billion in Q3 2025 and bottomed at $2.3 billion in Q4 2023.
  • The 5-year median for Revenue is $2.5 billion (2021), against an average of $2.5 billion.
  • The largest annual shift saw Revenue soared 49.29% in 2021 before it decreased 14.98% in 2022.
  • A 5-year view of Revenue shows it stood at $2.7 billion in 2021, then fell by 14.98% to $2.3 billion in 2022, then decreased by 1.93% to $2.3 billion in 2023, then rose by 14.55% to $2.6 billion in 2024, then grew by 7.06% to $2.8 billion in 2025.
  • Per Business Quant, the three most recent readings for DGX's Revenue are $2.8 billion (Q4 2025), $2.8 billion (Q3 2025), and $2.8 billion (Q2 2025).